Hjem › Småcellet lungekreft › Georgia
Kliniske studier for Småcellet lungekreft i Georgia
12 studier for Småcellet lungekreft søker deltakere på steder i Georgia.
Byer i Georgia
Offisiell studietekst (engelsk)
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Emory Winship Cancer Institute, Atlanta
- Augusta University, Augusta
RekruttererFase 1
Alder 19 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06586957DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Emory University, Atlanta
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07472517A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- City Of Hope - Atlanta /ID# 279929, Newnan
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07365241Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Emory University Hospital, Atlanta
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07278479A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Winship Cancer Institute at Emory University, Atlanta
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07488676A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
- Emory University, Atlanta
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07459634Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
- Winship Cancer Institute, Atlanta
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04342429A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital, Marietta
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06646276AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Atlanta
RekruttererFase 1/2
Alder 18 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07038343Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Northside Hospital Atlanta, Atlanta
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06712355Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. mar. 2026 · NCT06769126A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 114, Atlanta
- Research Site 139, Atlanta
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. nov. 2025 · NCT05914116Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.